Genomic Vision Logo

Genomic Vision

GV | PA

Overview

Corporate Details

ISIN(s):
FR0011799907
LEI:
969500UXJNBY1C8Y8471
Country:
France
Address:
80 RUE DES MEUNIERS, 92220 BAGNEUX
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Genomic Vision is a biotechnology company that develops advanced tools, services, and diagnostic solutions for genetic analysis. The company specializes in visualizing and characterizing individual DNA molecules through its proprietary Molecular Combing Technology, a nanotechnology platform for highly accurate DNA analysis. Its products and services are utilized in the research and diagnosis of cancer and inherited genetic diseases, as well as in drug discovery and biomanufacturing for cell characterization. Genomic Vision aims to establish new standards for DNA analysis to improve disease monitoring and treatment strategies.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Genomic Vision. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2023-11-17 18:00
Legal Proceedings Report
Inside Information / Other news releases
English 171.1 KB
2023-11-17 18:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 168.7 KB
2023-11-14 18:00
Legal Proceedings Report
Inside Information / News release on accounts, results
English 183.9 KB
2023-11-14 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 182.8 KB
2023-11-08 18:38
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
French 79.6 KB
2023-11-07 18:00
Board/Management Information
Informations privilégiées / Autres communiqués
French 165.9 KB
2023-11-03 18:00
Legal Proceedings Report
Inside Information / Other news releases
English 133.1 KB
2023-11-03 18:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 134.9 KB
2023-11-02 07:00
Earnings Release
Informations privilégiées / Autres communiqués
French 166.5 KB
2023-11-02 07:00
Environmental & Social Information
Inside Information / Other news releases
English 165.6 KB
2023-10-24 18:00
Regulatory News Service
Informations privilégiées / Autres communiqués
French 123.8 KB
2023-10-24 18:00
Regulatory News Service
Inside Information / Other news releases
English 122.3 KB
2023-10-19 09:29
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils
French 272.4 KB
2023-10-18 14:49
Major Shareholding Notification
Franchissement de seuils
French 272.6 KB
2023-10-12 07:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 157.0 KB

Automate Your Workflow. Get a real-time feed of all Genomic Vision filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Genomic Vision via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN